AbstractA case of complex partial status epilepticus (CPSE) with high dose treatment of tiagabine (TGB) is reported. Seizure aggravation and CPSE developed after stepwise increase of TGB to a dose of 60 mg per day as add-on treatment to carbamazepine (CBZ) 1200 mg/day and vigabatrine (VGB) 1000 mg/day. The EEG during CPSE showed bilateral rhythmic slow activity. Clinical symptoms of CPSE and the EEG normalized after i.v. treatment with clonazepam. The literature and the possible mechanism of this paradoxical phenomenon are discussed
AbstractWe describe a 30-year-old woman with an infantile-onset epilepsy due to a left temporal glio...
The mechanism of action of the new anticonvulsant drug tiagabine (TGB) is reuptake inhibition of GAB...
An 8-year-old girl with Lennox-Gastaut syndrome showed a partial reduction in seizure frequency when...
AbstractA case of complex partial status epilepticus (CPSE) with high dose treatment of tiagabine (T...
Tiagabine (TGB), a novel GABA reuptake inhibitor antiepileptic drug, has been reported to induce non...
AbstractThere have been several recent reports of non-convulsive status epilepticus during tiagabine...
Three patients who developed clinical evidence of non-convulsive status epilepticus while on high do...
We report a 4-year-old patient who developed non-convulsive status epilepticus (NCSE) following tiag...
AbstractA case of a 7-year-old male with epilepsy who developed non-convulsive status epilepticus (N...
or secondarily generalized seizures.6,7 We discuss here, a schizophrenic patient with EEG proven NCS...
Vigabatrin (gamma-vinyl-GABA or GVG) is an irreversible inhibitor of gamma-aminobutyric acid transam...
AbstractWe report a peculiar depth-EEG recording of prolonged post-ictal confusion which proved to b...
Tiagabine, a novel GABA reuptake inhibitor, has been reported to induce non-convulsive status epilep...
AbstractTiagabine, a novel GABA reuptake inhibitor, has been reported to induce non-convulsive statu...
Tiagabine is an antiepileptic drug used as adjunctive therapy for partial seizures that is believed ...
AbstractWe describe a 30-year-old woman with an infantile-onset epilepsy due to a left temporal glio...
The mechanism of action of the new anticonvulsant drug tiagabine (TGB) is reuptake inhibition of GAB...
An 8-year-old girl with Lennox-Gastaut syndrome showed a partial reduction in seizure frequency when...
AbstractA case of complex partial status epilepticus (CPSE) with high dose treatment of tiagabine (T...
Tiagabine (TGB), a novel GABA reuptake inhibitor antiepileptic drug, has been reported to induce non...
AbstractThere have been several recent reports of non-convulsive status epilepticus during tiagabine...
Three patients who developed clinical evidence of non-convulsive status epilepticus while on high do...
We report a 4-year-old patient who developed non-convulsive status epilepticus (NCSE) following tiag...
AbstractA case of a 7-year-old male with epilepsy who developed non-convulsive status epilepticus (N...
or secondarily generalized seizures.6,7 We discuss here, a schizophrenic patient with EEG proven NCS...
Vigabatrin (gamma-vinyl-GABA or GVG) is an irreversible inhibitor of gamma-aminobutyric acid transam...
AbstractWe report a peculiar depth-EEG recording of prolonged post-ictal confusion which proved to b...
Tiagabine, a novel GABA reuptake inhibitor, has been reported to induce non-convulsive status epilep...
AbstractTiagabine, a novel GABA reuptake inhibitor, has been reported to induce non-convulsive statu...
Tiagabine is an antiepileptic drug used as adjunctive therapy for partial seizures that is believed ...
AbstractWe describe a 30-year-old woman with an infantile-onset epilepsy due to a left temporal glio...
The mechanism of action of the new anticonvulsant drug tiagabine (TGB) is reuptake inhibition of GAB...
An 8-year-old girl with Lennox-Gastaut syndrome showed a partial reduction in seizure frequency when...